insights_auto
Kwa nini NVS imeongezeka kwa 3.14%?
Fahamu zaidichevron_right
NVS:NYSE
Novartis AG
US$ 146.88
arrow_upward
+3.14%(+4.47) Siku 1
US$ 146.88
0.00% (0.00)
bedtimeBaada ya saa
Imefungwa: 14 Okt, 16:00:03 GMT -4 · USD
search
Alama zote
| Alama | Bei | Tofauti | Tofauti ya asilimia |
|---|
insights_autoInatayarisha maarifa maarufu ya NVS...
Fungua
US$ 144.35
Juu
US$ 147.16
Chini
US$ 144.17
Mtaji wa soko
300.82B
Wastani wa kiasi cha mauzo
2.40M
Kiasi cha mauzo ya hisa
1.65M
Gawio
3.23%
Mgawo wa faida wa kila robo mwaka
US$ 1.19
Tarehe ya kutojumuisha gawio
10 Mac 2026
Uwiano wa bei ya hisa na mapato kwa kila hisa
22.18
Juu kwa wiki 52
US$ 170.46
Chini kwa wiki 52
US$ 121.57
EPS
US$ 6.62
Beta
0.39
Hisa za wawekezaji
2.03B
Idadi ya wafanyakazi
elfu 75
Fungua
US$ 144.35
Juu
US$ 147.16
Chini
US$ 144.17
Mtaji wa soko
300.82B
Wastani wa kiasi cha mauzo
2.40M
Kiasi cha mauzo ya hisa
1.65M
Gawio
3.23%
Mgawo wa faida wa kila robo mwaka
US$ 1.19
Tarehe ya kutojumuisha gawio
10 Mac 2026
Uwiano wa bei ya hisa na mapato kwa kila hisa
22.18
Juu kwa wiki 52
US$ 170.46
Chini kwa wiki 52
US$ 121.57
EPS
US$ 6.62
Beta
0.39
Hisa za wawekezaji
2.03B
Idadi ya wafanyakazi
elfu 75
Habari
Kutoka kwenye vyanzo vya wavuti na washirika wa habari
GuruFocus
·
saa 1 iliyopita
Novartis AG (NVS) Stock Up 3.1% but GF Value Says Overvalued -- GF Score: 68/100
Global Arbitration Review
·
saa 3 zilizopita
US biotech company enforces eye treatment award against Novartis
Quiver Quantitative
·
saa 4 zilizopita
Why Novartis (NVS) Stock Is Up Today
Investing.com Canada
·
saa 11 zilizopita
MindWalk adds three executives from Pfizer, Novartis, Arbor By Investing.com
Wasifu
Novartis AG is a Swiss multinational pharmaceutical corporation based in Basel, Switzerland. Novartis is one of the largest pharmaceutical companies in the world and was the eighth largest by revenue in 2024.
Novartis manufactures the drugs clozapine, diclofenac, carbamazepine, valsartan, imatinib mesylate, cyclosporine, letrozole, methylphenidate, terbinafine, deferasirox, and others.
Novartis was formed in 1996 by the merger of Ciba-Geigy and Sandoz. It was considered the largest corporate merger in history during that time. The pharmaceutical and agrochemical divisions of both companies formed Novartis as an independent entity. The name Novartis was based on the Latin terms, novae artes.
After the merger, other Ciba-Geigy and Sandoz businesses were sold, or, like Ciba Specialty Chemicals, spun off as independent companies. The Sandoz brand disappeared for three years, but was revived in 2003 when Novartis consolidated its generic drugs businesses into a single subsidiary and named it Sandoz. Wikipedia
Kuhusu Novartis AG
Afisa Mkuu Mtendaji (CEO)Vasant Narasimhan
Wafanyakazielfu 75.3
Lilianzishwa7 Mac 1996
Makao makuuBasel, Mji wa Basel, Uswisi
Sekta-
Tovutinovartis.com